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As a result of an initiative by Mr. Venkatesh Mannar, then a UNICEF salt 
consultant the micronutrient Initiative undertook a program to test the concept of 
double fortification of salt, and eventually to develop a process for double 
fortification with iron and iodine. All of the research and much of the development 
work on this program has been carried out by the University of Toronto. 
The program's goal is to develop technology for the double fortification of 
salt with iron and iodine, and to triple fortify with iodine, iron and Vitamin A. 
At this point in time, we have developed techniques for agglomeration and 
encapsulation of premixes containing iodine, iron, Vitamin A, and combined 
premixes for iodine and Vitamin A. Triple premixes, combinations of iron with 
either iodine or Vitamin A were unstable. 
We have developed techniques for colour masking ferrous fumarate 
premixes. Thus we have satisfied the need for providing a stable chemical 
platform, assured blending of the premixes with salt without segregation during 
manufacture distribution and retail, and minimized the visual impact of iron 
fortification in normal; household salt. 
The technology for double fortification works well with normally iodated 
salt, in highly refined household salt, using microencapsutated ferrous fumarate 
as the iron source. With unrefined, coarser salt larger premix particles must be 
made, and microencapsulated iodine premix is also required, to ensure iodine 
stability. 
Triple fortification was shown to be technically feasible. The stability of 
Vitamin A in the original formulations is relatively low, resulting in losses of some 
50% in 3-6 mooths of storage at high temperature and humidity. 
Field tests in Kenya and Nigeria confirmed the laboratory results on DFS 
and TFS stability. A number of formulations have been successfully field tested. 
Scale-up of microencapsulated iodine was completed to small commercial 
scale, while microencapsulated iron was produced at full commercial scale, and 
is ready for an initial commercial production run. 
A greatly simplified process, using a cement mixer for both agglomeration 
and encapsulation (coating) was technically feasible, though highly manpower 
intensive, as much material had to be reworked. 
The results of this work have been presented at several international 
congresses, and in numerous publications, some still in press. A list has been 
provided earlier. 
More technical details have been reported earlier, and also in the following 
chapters. 
1. Introduction 
Iodine and iron deficiency impacts over 2 billion people around the world. 
Insufficient intake of iodine in the diet causes a myriad of health problems 
collectively known as Iodine Deficiency Disorders (IDD). The consequences of 
IDD include mental retardation, goiter, growth retardation and increased neonatal 
and post-natal mortality (Venkatesh Mannar, 1987). 
Nutritional iron deficiency is also a major problem in developing countries, 
often affecting the same population group. Lack of sufficient iron intake can lead 
to increased maternal mortality, compromised development of motor skills and 
learning capacity, lethargy and reduced immunity to disease. The combined 
impact of these deficiencies severely impedes economic and social development 
in developing countries. (Clydesdale & Weimer, 1985). 
The quantity and cost of micronutrients required to combat these 
deficiency diseases seem trivial — only a few milligrams or micrograms per day 
costing only a few cents per person annually — yet the logistics of regularly 
providing these micronutrients pose serious social and technical challenges. 
Salt has been successfully fortified with iodine and this has virtually 
eliminated IDD in developed nations. It seems logical to utilize the infrastructure 
and experience established with salt iodization in providing iron to combat 
widespread anemia is. Salt is an excellent carrier for essential micronutrients in 
view of its almost universal and uniform consumption. Since salt is processed in 
relatively few production centres, its processing is easier to coordinate. 
(Narasingha Rao & Vijaya Sarathy, 1975; Zoller et al., 1980, Diosady et al, 1998) 
Adding iron and iodine concurrently to salt has its challenges. There are 
several factors that make direct addition of iron and iodine compounds to salt 
impractical. Iron and iodine compounds tend to react with each other and 
impurities normally present in salt and this leads to conversion of iodide or lodate 
to iodine in its elemental state (12). . The free iodine easily sublimes and is lost 
into the atmosphere.The oxidation of iodide or reduction of iodate to elemental 
iodine is accelerated by t metal ions and reducing and oxidizing agents, 
especially in the presence of moisture and sunlight, Iron compounds also 
undergo reactions that lead to discoloration of the salt and amplified metallic 
taste (Diosady, et al 1998; Yusufali, 2001). 
In the past two decades, there have been progressive attempts to produce 
double fortified salt. Indian scientists have used ferrous sulphate and sodium 
hexametaphosphate together with potassium iodide/iodate (Narasingha Rao, 
1990; Venkatesh Mannar, Jayapal, & Pandav, 1989). This approach, although 
stable at low humidity and temperature, is not commercially viable due to the 
high levels of additives required. When tested under high humidity and high 
temperatures typical of tropical countries, the double fortified salt showed poor 
stability. (Diosady et al, 2001) 
The stability of double fortified salt can be greatly enhanced by 
microencapsulation of the fortifying ingredients. Diosady et al. 2001 proved that 
double fortified salt prepared by microencapsulation of potassium iodide by spray 
drying within a dextrin matrix and ferrous fumarate added in dry powder form was 
stable for up to six months. Spray drying is limited in its application since the 
particles were very small in the range of 50-lOOjim. Typical salt particles are 
300-l500pm in diameter The spray dried premix particles would readily 
segregate in the salt and thus the salt was milled to a similar particle size range 
in order to ensure adequate mixing. This was undesirable from the consumers' 
point of view and would also increase the cost of producing double fortified salt. 
An alternate strategy for producing encapsulated iron and iodine premixes 
for double fortification of salt is presented here. The important criteria were 




Inert matrix (fillers and binders) 
Figure 1 Cross sectional view of an ideal encapsulated particle 
2. Experimental techniques 
2.1. Materials 
Non-iodized, high grade evaporated salt (food grade) was obtained from 
Toronto Salt Chemical Co., Toronto. Laboratory grade potassium iodide, 
potassium iodate, ferrous fumarate, dichioromethane, and food grade ethanol 
(100%) were purchased from Sigma-Aldrich Chemical Company, Toronto. 
A modified starch, Casco Dextrin 7071, from Casco Inc. Cardinal, ON. 
Canada, was used as a filler/binder. Fully hydrogenated soy stearine was 
obtained from CanAmera Foods Inc. of Toronto, ON. Canada. 
Analytical grade Polyethylene glycol (PEG 2000 & PEG 8000), palmitic 
acid, ethylcellulose, polymethyl methacrylate, hydrochloric acid and zein were 
purchased from BDH Chemicals Limited of Toronto. 
Reagent grade 1,10-phenanthroline monohydrate and potassium 
biphthalate were obtained from Sigma-Aldrich Chemical Co. of Toronto. An iron 
atomic absorption standard was purchased from SCP Science of Toronto. 
2.2. Pan Granulation 
Pan agglomeration was carried out in a rotating pan fabricated in our machine 
shop. The pan was 30 cm in diameter and 6 cm deep and was connected to a 
variable speed motor. The pan inclination angle could be varied by rotating the 
motor support shaft. A diagram of the pan is shown in figure 2. 
A typical granulation run consisted of blending the dry powder formulation 
using a 5L ribbon blender (LeRoy Somer-LSTronics, Montreal) or glass jar. The 
powder was then fed into the pan and the rotation speed and inclination angle 
was adjusted until a cascading motion of the powder in the pan was achieved. 
The binding solution consisting of 10% dextrin was then sprayed onto the powder 
in the pan using a TLC atomizer hooked up to an air supply at —50 kPa. Once 
the powder was granulated, the granules were placed in a baking pan and dried 
in an oven at 50°C for 12 hours. After drying, particles between 300um — 700um 
were recovered by sieving and spray coated. 
2.3. Spray Coating 
Spray coating of the particles was also done in the rotating pan. The 
particles to be encapsulated were fed into the rotating pan and set in motion. 
The encapsulant was dissolved in either alcohol or dichloromethane and sprayed 
using an air atomizer onto the particles. It was sometimes necessary to dry the 
particles in-between spraying. The mass of the particles was measured before 
and after each run to determine the level of encapsulation. The concentration of 
the encapsulant in the solvent was varied to decrease its viscosity to enable 
spraying. 
Figure 2 Diagram of rotating pan used for agglomeration and spray coating of particles 
2.4. Salt preparation 
Seven 50g salt samples in LDPE bags containing 5OpgIg iodine and 
1000 pglg iron were prepared for each formulation. Separate bags were 
prepared in order to minimize sampling error normally caused by segregation of 
particles within the bag. Appropriate amounts of iron and iodine premix particles 
were weighed into each of the bags. 
During analysis, the complete contents of each sample bag was first milled using 
a Black & Decker coffee grinder and sub-samples from the milled fortified salt 
were analyzed for iodine and iron content. 
2.5. Storage conditions 
The packages were stored under elevated temperature and humidity (40°C 
and —100%RH) to simulate extreme tropical conditions. The high temperature 
and humidity was maintained using a controlled temperature oven, in which the 
air was saturated with moisture by exposure to a tray of water. 
SIDE VIEW FRONT VIEW 
2.6. Analytical methods 
2.6.1 Iodine 
Iodine was measured by epithermal neutron activation analysis (ENAA) 
using a SLOWPOKE nuclear reactor with the help of Professor Ronald Hancock 
at the Royal Military College in Kingston, Ontario. 
In this method, 1-2 g samples of salt were weighed into polyethylene vials. 
These vials were then shielded with a cadmium shell and irradiated at 10 kW for 
3 minutes using a neutron flux of 5.0 x 1011 cm2s1. The cadmium shell was 
used to reduce interferences due to the high proportion of chlorine and sodium 
present in the sample. Following irradiation, there was a time delay of 6 minutes, 
after which the gamma emissions at 44.3 keV were measured using a hyper pure 
germanium based gamma ray spectrometer. The concentrations of iodine in the 
samples were calculated based on a calibration curve obtained from a series of 
standard samples ranging in iodine concentration from 20 to 2000 ppm. 
2.6.2. Iron 
Iron was analyzed by spectrophotometry, using the method developed by 
Harvey, Smart and Edwards (1955). 1,10-phenanthroline complexes are formed 
with iron(lI) and iron(lll) and. their absorbances are then measured at 396 nm 
and 510 nm and correlated to calibration data to determine the total iron and the 
ferrous iron content of samples simultaneously. The main advantage of this 
method is that it not only gives the total iron content but also differentiates 
between ferrous and ferric iron. 
2.6.3. Moisture content 
The moisture content of samples was determined gravimetrically. Samples 
weighing not less than 5g were weighed into aluminum boats previously dried in 
the oven at 110°C to remove moisture. The samples were then dried to constant 
weight in an oven at 110°C (12-24 hours) 
3. Results and Discussion 
The ultimate objective of double fortifying salt with iron and iodine is to 
provide these essential micronutrients to the countless people who's diets are 
deficient. In order to make these micronutrients available to everyone, the has to 
be simple, and relatively inexpensive resulting in fortified salt where the 
micronutrients are stable under typical storage and distribution conditions. 
3.1. Size Enlargement and Micronutrient Dosage 
In order to add these microencapsulated nutrients to salt, the particle size 
distribution of the premix had to match that of salt. Because of the differences in 
particle size between typical commercial salt crystals (300 to 700um) and the 
iodine and iron compounds (20 to 200 urn), segregation of the micronutrients 
would occur. Since finely powdered salt is not practical for household use under 
hot, humid conditions, increasing the mean particle size of the premix to match 
that of typical salt is a more practical approach to ensuring that no segregation 
occurs. Pan granulation was chosen as the size enlargement technique because 
it is a relatively simple and inexpensive compared to other granulation 
techniques. 
The iodine premix was diluted by 50-100 fold. This was necessary 
because a typical crystal if KI, the size of a salt grain would contain nearly the 
entire daily iodine requirement. Small errors in mixing would result in 
over/underdoseing the salt. It was prudent to adjust the concentration of the 
active micronutrients in order to ensure their safe delivery. 
Salt consumption is approximately 10 g per day. The dosage of active 
nutrients in the salt was set to provide 100% of the recommended daily intake of I 
and 30% of Fe: 50 ppm iodine and 1000 ppm iron in the salt would provide 0.5 
mg iodine and 10 mg iron daily. Studies show that only about one third of the 
consumed iron is actually absorbed by the body. SO? — did we account for this? 
Does the RDA take it into account? This may be a red herring that draws 
criticism unless we explain it away, and may be left out. 
For the process to be viable, the amount of premix will have to be limited 
to 1% of the salt. At lower inclusion levels even mixing is difficult, while higher 
levels significantly increase the cost of salt, and the pre-mix. To maintain the 
addition level at 1% of the salt weight the iodine premix consisted of 
approximately 1% iodine and the iron premix contained approximately 20% iron. 
We investigated 3 approaches to producing the premix particles. These 
are presented in the table below: 
Spray Drying Fluidized bed Pan 
granulation and agglomeration 
coating and coating 
Particle size Inappropriate, Appropriate, Appropriate, 
distribution averaging 50- process process 
lOOum in diameter parameters can parameters can 
be adjusted to be adjusted to 
produce particles produce particles 
averaging 250- averaging 250- 
700um 700um 
Cost High due to Capital cost quite Cost of equipment 
energy high although relatively low 
requirement and product yield is 
cost of equipment good 
Yield of particles Very low, most of High, but skilled Approximately 
within the the product is too personnel 50% yield, wide 
particle size fine required to control distribution of 
range process particle size but 
off sizes can be 
reworked. 




Flu idized bed processing or pan granulation can both be applied successfully for 
producing the encapsulated premix; its use would depend on the resources 
available. We have performed scale-up studies for both approaches with relative 
ease from 1 to 22 to 60 and finally 225L reactor batch sizes. 
We used dextrin as a filler and a binder for granulation runs. 
Approximately four fifths of the dextrin was combined with ferrous fumarate as a 
dry powder and fed into the rotating pan. The pan was set into motion and the 
angle of inclination and the rotation speed was adjusted until the powder flowed 
in a cascading motion. The binding solution consisting of the remaining dextrin 
as a 10% aqueous solution was prepared and sprayed onto the powder in order 
to agglomerate the powder. The spray rate ? not volume? was adjusted until 
sufficient agglomeration took place. 
The iodine premix was agglomerated similarly with the exception that only 
dextrin was fed into the pan and the binding solution consisted of a solution of 
dextrin, potassium iodide and water (10% solids content). 
3.2. Microencapsulation and selection of suitable encapsulants 
The agglomerated particles were further protected by a water impervious 
surface film, by microencapsulation. Encapsulation was achieved by spray 
coating in the pan granulator. The encapsulant was dissolved in either methylene 
chloride or ethanol. The spray rate was kept low in order to prevent further 
granulation. 
The criteria used in rating the performance of the microencapsulated nutrients 
were iodine retention, iron conversion, color and taste. 
Salt fortified with uncoated, agglomerated ferrous fumarate and potassium iodate 
lost all its iodine in 3 months under 40°C and 100%RH. There was 25% 
conversion of ferrous iron to ferric iron as well and the salt turned blue in color. 
Salt fortified with agglomerated ferrous fumarate and potassium iodide however, 
retained almost all the iodine but it had also turned blue. This suggests that 
there was leakage of iron from the granulated premix which in turn led to the blue 
color formation, hence there was a need for further protection of the active 
nutrients. In previous studies by Diosady et al. the blue color of the salt wasn't 
observed with potassium iodide and ferrous fumarate, indicating that spray- 
drying, results in a more stable capsule. 
From stability results of the unencapsulated, agglomerated premix, it was clear 
that added protection of the iron and iodine premix was desirable. Encapsulation 
with a coating agent the would 
• form continuous films; 
• be impervious to water; 
• It should be edible and easily digestible, and 
• provide the required protection for the micronutrients. 
Several encapsulants were investigated.. The performance of the encapsulant 
was judged by the retention of iodine after 3 months of storage under 40°C and 
100% RH. 
Kl03 particles were agglomerated and subsequently coated with 40% w/w 
of the coating agent.. Ferrous fumarate was also agglomerated and coated with 
soy stearine at the 40% level. Each of the encapsulated K103 premixes was used 
to fortify salt together with ferrous fumarate and encapsulated ferrous fumarate 
respectively. A total of 14 batches were stored at 40°C and 100% RH for three 
months and analyzed for iodine content at the end of this time period. Figures 3 
and 4 depict the iodine retention of each of the batches after 3 months of 
storage. 
With 40% encapsulant, soy stearine, palmitic acid, and polymethyl methacrylate 
encapsulated batches showed exceptionally good iodine retention. The 4O% encapsulation 
level was chosen as an upper limit, beyond which further encapsulant addition was 
impractical, and encapsulant that did not work at this level were not pursued furthere. 
Following successful identification of three possible encapsulants, soy stearine and was 
chosen for further optimization studies due to its low cost, availability and acceptability in 
food regulations. 
A factorial experimental design was followed in investigating combinations involving 
two iodine compounds (KI and 1<103) and one iron compound (ferrous fumarate) as active 
nutrients and soy stearine as an encapsulant. We studied soy stearine encapsulation at 0,5%, 
1 0%, 20% and 30% on 1(1 and 1(10 3and at 15% and 30% on ferrous fumarate. 

3.4. Effect of encapsulation on iodine retention, iron conversion and color 
Potassium iodate and potassium iodide are the most widely used compounds for salt 
iodization. Potassium iodate is more favored in developing countries and is recommended 
for salts with higher moisture contents. Potassium iodate however, can be easily reduced in 
the presence of ferrous salts to free iodine. For optimizing the formulation, both iodine 
compounds were investigated. You just said thisin the previous section! 
3.4.1. Potassium iodide and ferrous fumarate 
The iodine retention in formulations containing potassium iodide was generally 
higher than those containing iodate. The encapsulation level on potassium iodide premix or 
iron premix did not have a significant effect on iodine stability; the retention of iodine was 
more than 90% in all combinations. The level of coating did have a significant effect on 
iron conversion and the color of the salt. The amount of ferrous iron converted to ferric 
iron dropped from about 35% to 5% as the level of encapsulation on the iodine premix was 
increased from O% to 30%. At the higher coating levels the color of the salt remained 
completely white. 
Figure 5 Retention of iodine in batches double fortified with soy stearine encapsulated KI 
premix and soy stearine encapsulated ferrous fumarate premix after 3 months of storage 







30% SS -Fefum 
15% SS -Fefum 
-? 0% SS -Fefum encaps. 
on Iron 
10%SS 
% encaps. on Iodine 20% SS 
30% SS 
Figure 6 Conversion of ferrous iron to ferric iron in batches double fortified with soy 
stearine encapsulated Kl premix and soy stearine encapsulated ferrous fumarate premix 
after 3 months of storage at 40°C and 100%RH. 
Iron conversion generally correlated with iodine retention and color. Greater iron 
conversion was noticed in batches with lower iodine retention. The iron conversion also 
corresponded directly with the color of the salt. Batches which turned blue or green had 
higher conversion of ferrous iron to ferric iron, thus decreasing its bioavailability. Visual 
observations of color could therefore be used to qualitatively assess iron conversion. 
3.4.2 Potassium iodate andferrousfumarate 
For batches containing potassium iodate, the level of soy stearine coating on the iron 
premix had a very significant impact on iodine retention. The iodine retention when the 
ferrous fumarate was not coated was close to 0% and when the ferrous fumarate was coated 
with 30% soy stearine the iodine retention was around 80%. 
This suggests that there is significant leakage of iron from the microparticles. The ferrous 
iron, if not adequately contained, leaches out and comes into contact with the iodate ion 
resulting in a reaction which leads to reduction of iodate to iodide and oxidation of ferrous 
to ferric ion. 
The level of soy stearine coating on the potassium iodate did not have a very 
significant effect on iodine retention. This was expected, as the salt was highly purified, and 




o 15-20 25- 
% conversion of 010-15 




30% SS -Fefum 
0 
0% SS 15% SS -Fefum 
5% SS % encaps. on iron 
10% SS 0% SS -Fefum 
20% SS 
% encaps. on Iodine 30% SS 
Protecting the iron compound is therefore necessary in systems where potassium 
iodate and ferrous furnarate are used. When Potassium iodide is used with ferrous fumarate 






30% SS -Fefum 
15% SS -Fefum 
% encaps. 
0% SS -Fefum 
on Iron 
30% SS 
Figure 7 Retention of iodine in batches double fortified with soy stearine encapsulated 
Kb3 premix and soy stearine encapsulated ferrous fumarate premix after 3 months of 
storage at 40°C and 100%RH. 
Figure 8 conversion OT Terrous iron to iron in batches double fortified with soy 
stearine encapsulated Kb3 premix and soy stearine encapsulated ferrous fumarate premix 
after 3 months of storage at 40°C and 100%RH. - 
4. Conclusions 
The highest prevalence of iodine and iron deficiency is found in developing 
countries. In majority of these countries, the salt that is available is not refined and contains 
many impurities, including iron compounds. The presence of these impurities and the fact 
that the climate in most developing countries is warm and humid presents a challenge for 
double fortification of salt. 
We have shown that microencapsulation can be used to protect the micronutrients 
from losses due to unwanted reactions. Encapsulation provides a physical barrier that 
prevents contact between the active nutrients and the surroundings and hence increases 
stability. Microencapsulation through spray drying was successfully applied by Diosady et al. 
but it had its limitation is terms of particle size and cost. We have demonstrated than 
agglomeration followed by encapsulation by using a rotating pan is possible. Successful 
initial scale-up trials using a larger rotating pan were done at Weetabix Canada Limited in 
Cobourg, ON, Canada. 
This simple industrial process can cost-effectively produce premix for double 
fortified salt. Further research and development aimed towards better encapsulating agents 
and making the reddish-brown color of the ferrous fumarate premix more cosmetically 
appealing is desired. We are currently pursuing different processes and formulations aimed 
at improving the functional characteristics of double fortified salt. 
5. Triple Fortification 
5.1 Vitamin A Physical and Chemical Properties 
Vitamin A is a fat-soluble vitamin that is essential for the health of human beings. 
It comprises of a family of molecules containing a 20 carbon structure with a methyl 
substituted cyclohexenyl ring and a tetraene side chain with a hydroxyl group (retinol), 
aldehyde group (retinal), carboxylic acid group (retinoic acid), or ester group (retinyl 
ester) at carbon 15. 
The term vitamin A also includes provitamin A carotenoids that are dietary 
precursors of retinol. The term retinoids refers to retinol, its metabolites and synthetic 
analogues that have a similar structure. 
Preformed vitamin A is a yellow crystalline powder or oil. Carotenoids are 
reddish-brown to deep violet crystalline powders. Preformed vitamin A is found only in 
animal-derived food products (e.g. liver, dairy products, eggs and fish), whereas dietary 
carotenoids are present primarily in oils, fruits and vegetables. 
Vitamin A is extremely sensitive to oxygen (undergoes oxidation), light (promotes 
c/s-trans isomerization), heat (catalyzes trans to c/s isomerization), halogens (forms 
mixture of cis-trans isomers, particularly in the presence of light and high temperature), 
and is unstable in acidic environment (undergoes rearrangements of the double bonds 
and dehydrates). 
In all fat-soluble vitamins, esters are significantly more stable than alcohols as 
the free hydroxyl group of their alcohol forms is highly sensitive to oxidation. 
5.2 Iron 
Iron can exist in oxidation states ranging from -2 to +6. In biological systems, 
these oxidation states occur primarily as ferrous (+2), ferric (+3), and ferryl (+4) states. 
The following physical-chemical properties should be taken into consideration when 
choosing the source of iron fortificant: 
• Ferrous salts can be utilized/bioabsorbed more efficiently than ferric salts 
• Ferrous salts are more soluble than ferric salts 
• Ferrous salts are more reactive than ferric salts in food systems 
• Ferric iron generally has a greater tendency to form complexes than 
ferrous iron; the formation of complexes will greatly reduce iron bioavailability 
Ferrous salts are easily oxidized to ferric salts, which are usually orange or dark 
brown in colour. 
I 
(green) (orange/red) + e 
This reaction is promoted in alkaline and high humidity conditions, in the 
presence of oxidizing agents and common salt impurities such as magnesium chloride 
or sulphate. Salt containing oxidized iron, especially ferric sulphate, exhibits metallic 
taste and discoloration. [10] 
Electrolytic iron usually contains more than 96% iron. It is almost insoluble in 
water and has lower bioavailability than soluble iron salts. Other disadvantages are the 
dark grey colour and high density which could lead to organoleptic problems and 
segregation. 
Ferrous fumarate is a reddish orange to reddish brown powder that is odourless 
and almost tasteless. As for ferrous sulphate it is only slightly soluble in water. Ferrous 
sulphate is the cheapest and most widely used iron source in food fortification. It is 
used in two forms: heptahydrate and anhydrous ferrous sulphate. The anhydrous 
ferrous sulphate is grayish white in colour; it has a metallic and astringent taste. In 
contact with water it hydrates to form the light green heptahydrate, which is sparingly 
soluble. 
Ferric sodium EDTA is a pale yellow water-soluble powder with a high stability 
constant. [11] 
Many researchers indicate that while iron absorption from simple iron salts such 
as ferrous sulphate is very sensitive to inhibiting substances in food, the absorption from 
ferric NaEDTA is apparently not. [12, 13] While both ferric iron and iron complexes are 
typically poorly available, the literature seems consistent in considering ferric EDTA to 
be bioavailable. 
5.3 Iodine 
Iodine is a dark purple crystalline non-metallic element, which is insoluble in 
water, but soluble in many organic solvents. In human beings it is a constituent of the 
thyroid hormones, thyroxine T3 and T4 produced by thyroid gland. 
Two compounds of iodine are currently used for iodization: potassium iodate and 
iodide. The Codex Alimentarius standard for food grade salt permits the use of their 
sodium and potassium salts in the iodization program. 
lodides are readily oxidized when in contact with oxygen in a high humidity 
environment resulting in the formation and sublimation of free iodine. This process is 
accelerated in the presence of acidic salt impurities, high temperature and sunlight. [10] 
2 
2l 12 + 2e 
lodates are already oxidized thus they are more stable in tropical and subtropical 
climates. However, presence of salt impurities also promotes reduction of iodate to 
form free iodine. [10] 
-> 
Reduction: + 10 e 12 
A major consideration in the choice of the two compounds is the purity of the salt. 
The iodides are more readily degraded in the presence of impurities and high humidity 
environment, whereas the iodates remain stable in salt of lower quality. 
Potassium iodate (Kb3) and potassium iodide (KI) were used for this study. 
Potassium iodide is highly soluble in water (1440 gIL at 20°C) and the iodine content is 
75%. Most of the salt used in the affected areas is unrefined, thus the more stable Kl03 
is commonly used there for iodization. Solubility of Kl03 in water is very low (81.3 gIL at 
20°C) and its iodine content is 59.5%. [15] 
5.4 Recommended daily intakes, and target fortification levels 
In 1965, a Joint FAOIWHO Expert Group set a recommended daily intake of 
retinol as 750 RE/day. Vitamin A is a fat-soluble vitamin and can be therefore stored 
by human bodies. 
In general, iron requirements for adult males amount to 0.7 — 1.2 mg/day (about 
14 Requirements for adult females are between 1.2 — 2.5 mg/day (20 to 40 
jig/kg). The greater range is due to the variability of menstrual blood loss. 
The Recommended Daily Intake (RDI) for adult humans is 100 - 200 pg/day and 
the tolerable Upper Intake Level for adults is 1,100 jig/day. [16] 
The iodized salt is becoming the most common source of iodine, with about 70% 
of the salt consumed being now iodized. The level of fortification that has been used 
ranges from 15-200 ppm. Numerous regional factors have to be considered when 
designing iodized salt, including per capita salt consumption, degree of iodine 
deficiency, required shelf life, and climatic conditions. 
Accordingly our IFS fortifications were set at 50 pg/g iodine, 1000 pg/g iron and 
retinol 
5.5 Vitamin A and Iron Interactions 
A direct correlation between haemoglobin and serum retinol concentration has 
been observed. Intervention studies among Indonesian girls have demonstrated that 
3 
combining vitamin A with iron supplementation was more effective in increasing 
haemoglobin concentrations than iron alone. Various studies suggest that VAD impairs 
iron mobilization from body stores and therefore vitamin A supplementation improves 
haemoglobin concentrations. [21, 22, 23] 
However, ferrous salts are easily oxidized by iodates resulting in formation and 
sublimation of free iodine. 
103+ + + 3H20 
+ 312 + 3H20 
Ferric salts can be reduced by lodides: 
12 + 
The rate of these reactions depends mainly on the nature of the food and the 
environment. The reactions are accelerated in the high humidity environment. 
5.6 Designing Triple Fortified Salt 
The basic idea behind the design of a premix is to physically separate the active 
ingredients from each other or a harmful environment. This has been done with iron 
and iodine in the preparation of double fortified salt (DFS). The DFS prepared by the 
food engineering group of the University of Toronto was stable for 12 months at 40°C 
100% RH. [33] 
The premix microcapsule consists of small particles that contain an active 
nutrient and binding and, if needed, diluting agents surrounded by a moisture resistant 
coating or shell composed of materials such as polymers, carbohydrates, fats and 
waxes. Microencapsulation is a useful tool for protecting the integrity of pharmaceuticals 
and food ingredients such as vitamins, salts or flavours from oxygen, water and light. 
Figure 8 is a simplified drawing of an ideal premix particle, containing a 
micronutrient, binders, fillers and a layer of coating. 
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The premix must be: 
• Non-toxic and all constituents must be approved food additives in all 
targeted countries 
• Physically and chemically stable under the targeted environmental 
conditions 
• Bioavailable 
• Uniform, with the same particle size as salt, to avoid segregation 
• Sufficiently hard and tensile to avoid breaking during mixing with salt, 
storage and distribution 
• Inexpensive 
• be white/off white and tasteless so that the sensory properties of salt are 
not changed. 
Iron compounds used for fortification can be divided into two major groups: water 
soluble compounds and insoluble compounds. Ferrous sulphate, ferrous fumarate, 
ferrous ammonium sulphate, ferric ammonium sulphate, ferric ammonium citrate and 
ferric EDTA are examples of soluble compounds which were previously used for salt 
fortification. Some insoluble compounds are ferric phosphate, sodium iron 









Figure 7: A simplified cross sectional structure of a premix. 
A list of common iron compounds that have been previously used by our group in 
salt fortification, their bioavailability and relative cost is summarized in table 2.3 [101. 
The relative costs were calculated on the basis of the iron compound, cost and 
bioavailability of each compound. 
Table 5.1: Iron content and the bioavailability of some iron compounds 
previously used for salt fortification. 1101 
Iron Compound % Fe Content Relative Bioavailability Factor 
Relative 
Cost Factor 
iron 98 [ 0.13-0.90 




Sulphate x 7H20 
20 1.67 
Ferric NaEDTA 13 2.50 2.57 
The main problem in selecting an iron compound for fortification is that the ones 
with good relative bioavailability are more likely to be unstable under storage conditions, 
cause discoloration and changes in flavour or odour. Conversely, the lower the relative 
bioavailability, the more iron needs to be given to achieve the required effect, thus 
increasing cost and the probability of inducing undesirable side effects. [11, 53] 
5.7 Granulation Technology 
Granulation is a process by which a powder mixture is converted to larger free 
flowing particles called granules. The reasons for granulation are: 
To obtain sufficiently large particles that will not segregate from the salt 
To obtain the desired granule hardness and roughness 
To obtain the desired density 
Granulation normally follows initial dry mixing of the necessary powdered 
ingredients so that a uniform distribution of each ingredient through the premix is 
achieved. For economic and technical reason premix should be mixed with salt in 
:100 ratio. Refined salt crystals are between 300 and 800 in diameter and the 
size of the premix needs to match the size of salt to avoid segregation. 
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Excipients are materials used in the manufacturing or the compounding process 
for the purposes of maintaining the appearance (colour and consistency), protecting the 
active species (antioxidants), disguising any unpleasant taste/smell (sugar, flavouring 
agents), changing the dissolution rates of active species (coating, matrix) and 
manufacturing (fillers/diluents, lubricants and glidants). 
Fillers and binders do not have pharmacological activity themselves and are 
used to dilute the micronutrients and to bind them to form granules of the desired size. 
The binder has to allow the micronutrient absorption after premix ingestion. 
The function of a filler is to increase the bulk volume of the premix so that the 
final product has the proper volume. The filler has to be inert, compatible, non- 
hydroscopic, soluble, compactable and inexpensive. The most common fillers are: 
lactose, sucrose, glucose, mannitol, sorbitol, calcium phosphate, calcium carbonate, 
and cellulose. Lactose is the most widely used filler in the food industry. It offers good 
stability and fair protection for micronutrients sensitive to moisture. 
The function of a binder is to ensure that granules can be formed with required 
mechanical strength. Binders may be added to the mixture prior to the granulation 
process as a dry powder, or in the solution that is used for agglomeration in wet 
granulation processes 
The most common binders are: 
• Wet/Solution binders: acacia, gelatin, cellulose, cellulose derivatives, 
polyvinyl pyrrolidone, starch, sucrose, polyethylene glycol. 
• Dry binders: cellulose, methyl cellulose, polyvinyl pyrrolidone, 
polyethylene glycol 
• Some compounds, e.g. sodium hexametaphosphate (SHMP) can be used 
as both a binder and a stabilizer. 
Starch, a complex carbohydrate, is abundant in the seeds of cereal 
plants. It is an inexpensive dilutent/binding agent widely used by commercial vitamin A 
producers. The disadvantage of starch is that it has a tendency to absorb moisture. 
Industrial dextrin is granular starch with lower molecular weight. Its molecules 
are reorganized by roasting or by chemical modifications, causing the granules to be 
cold water-soluble. Depending on the degree of roasting, dextrins are categorized as 
white and yellow dextrins and British gum. 
Both, starch and yellow dextrin, were used in the vitamin A, iron and iodine 
premix preparations. 
Three granulation techniques were used in this program: 
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Wet granulation — wet mixing of a powder mixture with liquid adhesives followed 
by wet screening or granulation. The granulation liquid (usually water) may be used 
alone or, more usually, as a solvent containing a dissolved adhesive (also referred to as 
a binder or binding agent) that is used to ensure particle adhesion once the granule is 
dry. 
Fluidized bed granulation — is a single step process of mixing the powders and 
developing granules. This process requires only one piece of machinery that mixes the 
powder and granules on a bed of air. It is becoming a commonly used method because 
of the high quality of its products, convenience and the availability of suitable 
equipment. 
Spray drying - is the most widely used industrial process involving particle 
formation and drying. It is highly suited for the continuous production of dry solids in 
either powder, granulate or agglomerate form from solutions, emulsions or pumpable 
suspensions. 
Table 2.4 shows the advantages and disadvantages of the methods used for 
agglomeration. 
Table 5.2: The advantages and disadvantages of the methods used for 
agglomeration. [34] 




Highest probability of meeting 
the requirements for making a 
successful particle 








Useful for water and heat 
sensitive active ingredients 
Fewer_steps 




Can prepare a premix from 
powdered mixture without 
granulation 
Faster 
Requires materials that can be 
directly compressed 
Excipients must have good 
flow properties 
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Process Advantages Disadvantages 
Useful for crystalline 
premixes 
Useful for ingredients that are 
moisture sensitive 
Limited number of excipients 
- optimal bioavailability 
Can get non-uniform granules 
Limited size range of particles 
Fluidized Bed 
Granulation 
Requires only one piece of 
machinery (saves labor cost, 
transfer losses and time) 
Process can be automated 
after initial process optimization 
Expensive equipment 
The optimization of process 
requires extensive research (there 
are many apparatus, process and 
product variables which influence the 
granulation) 
The method and conditions of granulation affect intergranular and intragranular 
pore structure by changing the degree of packing within the granules. A simple bonding 
holds precompressed granules, consisting of compressed micronutrients and binder 
particles, together during compaction. Granules prepared by wet massing consist of 
intact active ingredients held together in a sponge-like matrix of binder. Fluidized-bed 
granules are similar to those prepared by the wet massing process, but possess greater 
porosity and a film of binding agent covers the granule surface. With spray-dried 
systems the granules consist of spherical particles composed of an outer shell and an 
inner core of particles. [34] 
Common equipment used in the industry for granulation is listed in table 2.5. 
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Table 5.3: Common equipment used for granulation. 
Wet Granulation Dry Granulation 
Shear granulators Sluggers 
High speed! mixer granulators Roller compactors 
Fluidized bed granulators 
Spray-driers 
Spheronizers/ pelletizers 
Extrusion ! Spheronizes 
Tumblers 
Tumblers 
The particles of a granular mass will cohere when they are tumbled and sprayed 
lightly with a liquid binder. The growth may be due to agglomeration of small particles or 
layering of material evaporated from the sprayed solution. Rotary kilns of the kind used 
for drying or chemical reaction (cement or lime burning, for instance) are adapted to 
size enlarging service. Usually the tumbling action is not very intense, only enough to 
expose the material to sprays. The sprays are fine and are applied to the surface of the 
bed of particles. The tumbling action then distributes the liquid uniformly through the 
mass. [36] 
Spray Dryers 
Spray drying involves the atomization of a liquid feedstock into a spray of 
droplets and contacting the droplets with hot air in a drying chamber. The sprays are 
produced by either rotary or nozzle atomizers. Evaporation of moisture from the droplets 
and formation of dry particles proceeds under controlled temperature and airflow 
conditions. Powder is discharged continuously from the drying chamber. Operating 
conditions and dryer design are selected according to the drying characteristics of the 
product and powder specifications. 
Pan Granulators 
The pan granulator consists of a tilted pan (inclined 300 to 60°) mounted on 
motor drive unit. The powder mixture is fed into the pan and the gravitational and 
centrifugal forces force the particles to move within the pan. Standard spray nozzle is 
employed to deliver small quantities of binding solution to create a basic adhesion 
between the particles. The granulation is done by the snowballing effect of the rotating 
disc. The rotation speed and angle depend on the size of the mixture. Too high speed 
10 
coating. 
= [(g sin tp)I (2ir2D)]112 
Fluidized Bed or Würster Granulators 
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will force the mass to the pan rim due to centrifugal forces; with too slow rotation sliding 
with no mixing will occur. 
The required disc-rotation speed is given in terms of the critical speed, i.e., the 
speed at which a single particle is held stationary on the rim of the disc due to 
centripetal forces. The critical speed is given by: 
Where g is the gravitational acceleration, q is the angle of the disc to the 
horizontal, and D is the disc diameter. The typical operating range for discs is 50 to 75% 
of critical speed, with angles p of [37] 
Figure 8 shows a diagram of rotating pan used for both agglomeration and pan 
Figure 8: (a) Edge and face view of a pan granulator; (b) Stratification of 
particle size during rotation [36] 
During agglomeration, the finer particles settle to the bottom and the largest 
remain at the top. Because of the size stratification, the product of disk granulation is 
more uniform in size than of drum granulators, which discharge a mixed product. 
The fluidized bed granulation process (also known as agglomeration) involves 
suspending particulates in an air stream and spraying a liquid from the top down onto 
the fluidized bed (figure 2.6). Particles in the path become tacky, collide with other 
particles and adhere to them to form granules. 
4 Binding solution inlet 
ii 
114 
Bed of suspended particles 
Fluidizing air inlet 
Figure 9. Fluidized Bed [38] 
There are two different modes of fluidized bed granulating: dry stage and wet 
stage. In dry stage granulation, the particles only require a slight wetting to become 
tacky and stick to each other. The granulating solution is applied at a rate less than or 
equal to the evaporation rate. Thus the particles remain "dry" through the entire 
process. In wet stage granulation, the particles require significant wetting before they 
become tacky enough to stick to each other. The granulating solution is applied at a rate 
higher than the evaporation rate until the particles build up enough moisture to 
granulate. The characteristics of the particles when wet and the type of granulating 
solution that is being used will determine which mode of granulating is most appropriate. 
While dry stage is more common, wet stage granulating allows for denser products. [36, 
39] 
5.8 Microencapsulation Technology 
Microencapsulation is done in order to protect the micronutrients against 
deterioration by environmental factors such as sunlight, temperature variations, 
moisture etc., to maintain physical and chemical integrity of premix and to enhance 
product acceptance and appearance. 
The choice of the coating material often depends on the purpose of 
microencapsulation and it is often crucial to achieving these goals. There are over a 
hundred substances suited (and already used) to form microcapsule films. 
They can be put into roughly five categories as follows: [40] 
• Polysaccharides/hydrocolloids, such as starch, algin/alginate, 
agar/agarose, pectin/polypectate, carrageenan, and other gums. 
• Proteins such as gelatin, casein, zein, soy, and albumin. 
• Fats and fatty acids such as mono-, di- and triglycerides, and lauric, 
capric, palmitic and stearic acid and their salts. 
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• Cellulosic derivatives such as methyl- and ethyl-cellulose. 
• Hydrophilic and lipophilic waxes such as shellac, PEG (polyethylene 
glycol), or carnauba wax or beeswax. 
In several cases, mixtures of these compounds can be used to obtain better 
results. 
Methocel, ethocel, shellac and soy stearine are commonly used coating agents 
which werealso used for the premix preparations. 
Methocel (methyl-cellulose, MC) is soluble in cold water, GI fluids and organic 
solvents. 
Ethocel (ethyl-cellulose, EC) cannot be used alone because it is totally insoluble 
in water and Gl fluids, Its main purpose is to toughen the film. EC is soluble in ethanol 
and other organic solvents. 
Shellac is pH dependent, soluble in water (at pH > 7) and some organic solvents 
(isopropanol, benzalcohol) and insoluble in GI fluids. 
Soy stearine is fully hydrogenated soy oil with melting point 60°C. It is 
insoluble in water, soluble in organic solvents such as hexane, ether and 
dichloromethane. 
The coating of solid particles can be done in a rotating pan and a fluidized bed. 
6. Experimental Techniques and Analytical Methods 
6.1 Materials Used 
All chemicals used, their suppliers and grades are listed in table 6.1. 
Table 6.1: List of materials used 
Material Producer Grade 
1,10 Phenantroline Sigma Chemical Co., St. Louis, USA 
Butylated hydroxyanisole, BHA Sigma Chemical Co., St. Louis, USA Food 
Butylated hydroxytoluene, 
BHT 
Sigma Chemical Co., St. Louis, USA Food 
z Casco, Toronto, ON Food 
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Material Producer Grade 
Dichioromethane EM Sciences, Gibbstown, NJ Laboratory 1 
iron, reduced EM Sciences, Gibbstown, NJ ACS 
Ethanol, 95% Commercial 
Ethocell DOW Chemical Co., Midland, Michigan Drug 
Ferric NaEDTA Aldrich Chemical Co Inc., Milwaukee, 
USA 
ACS 
Ferrous Fumarate Sigma Chemical Co., St. Louis, USA ACS 
Ferrous Sulphate Sigma Chemical Co., St. Louis, USA ACS 
Hexane EM Sciences, Gibbstown, NJ Commercial, 
b.p. 60 
- 68°C 
Hydrochloric acid BDH Inc., Toronto, ON Laboratory 





DOW Chemical Co., Midland, Michigan Drug 
Sigma Chemical Co., St. Louis, USA 
1 [ Laboratory 1 
Potassium Hydroxide Aldrich Chemical Co Inc., Milwaukee, 
USA 
Laboratory 
Potassium lodate Aldrich Chemical Co Inc., Milwaukee, 
USA 
ACS 
Potassium Iodide Aldrich Chemical Co Inc., Milwaukee, 
USA 
ACS 
Pyrogallic Acid Aldrich Chemical Co Inc., Milwaukee, 
USA 
ACS 
Salt, iodized Sifto Canada Inc, Mississauga, ON Food 1 
Salt, non-iodized Cargill Food Inc., Mineapolis, USA Top-flo® 
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Material Producer Grade 
uniodiz 
ed salt 
Shellac A.S. Paterson Co. Ltd, Toronto, ON Drug 
Sodium Tiosulphate BDH Inc., Toronto, ON ACS 




LStarch, white Casco, Toronto, ON Food 
Sulphuric acid BDH Inc., Toronto, ON Laboratory 
Tert-Butyl Hydroquinone, 
TBHQ 
Sigma Chemical Co., St. Louis, USA Food 
Titanium Dioxide EM Sciences, Gibbstown, NJ Food 
Vitamin A acetate BASF Corporation, New Jersey, USA Food 
Vitamin A palmitate BASF Corporation, New Jersey, USA Food 
Vitamin A palmitate Watson Food Co., Inc., West Haven, 
USA 
Food 
Vitamin A palmitate Roche Vitamins Inc., Parsippany, USA Food 
1 
Vitamin A, USP standard USP Rockville MD, USA Analytical 
For vitamin A premix, nine commercial vitamin A forms in two different forms 
(palmitate and acetate) were tested. Six of them are produced by BASF Corporation, 
two by Roche Vitamins Inc. and one by Watson Foods Co., Inc. The vitamin A forms 
differ in the composition of their matrix, bloactivity and the type of antioxidant they are 
stabilized with. Detailed description can be found in table 3.2. 




[I.U./gJ Matrix Product Number 
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Vitamin A Bioactivity 
(I.UJg] Matrix Product Number 
BASF Dry VAP 
250 Food 
250 000 E 414, sucrose, starch, E 307, E 341 Prod:303081 
Lot:200719Y0 & 
483111U0 
BASF Dry VAP 
250 CK CWD 








L t029119YO °. 
BASE Dry VAP 
250 CWD 
250 000 gelatin, sucrose, starch, BHT, E 554 Prod:306325 
Lot:11344182 
BASF Dry VAP 
500 




BASE Dry VA 
Acetate 500 
500 000 gelatin, sucrose, modified starch, 
BHT, E 554 
Prod:303064 
Lot:20830174 
Roche Dry VAP 
500 
500 000 corn starch, gelatin, sucrose, BHT, Prod: 0483834 
Lot:WB00104197 
Roche Dry VAP 
250 SIN 
250 000 modified starch, sucrose, fractionated 
coconut oil, E 301, sodium benzoate, 










Note: E 301-sodium ascorbate (antioxidant), E 307-DL-alpha-tocopherol (USP/FCC, antioxidant), 
E 341- tricalcium phosphate (anti-caking agents), E 414 - gum Arabic, E554- sodium aluminium silicate 
(anti-caking agents) 
Products 1, 2, 3 and 4 are dispersible even in cold water (10°C) and form a 
stable milky emulsion. [44]. Products 5 and 6 are dispersible in warm water (35-40°C) 
and form a milky emulsion. [44]. Roche Dry VAP 500 is insoluble in water. [45] 
Roche Dry VAP 250 S/N disperses quickly and completely in cold water. High 
concentrations produce cloudy dispersions, which, however, remain uniform for 
relatively long periods. [46] 
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Vitamin A palmitate from Watson dissolves in cold water resulting in a cloudy 
dispersion. [57] 
Four forms of iron used in this study were electrolytic iron, ferrous fumarate, 
ferrous sulphate and ferric NaEDTA. These sources were chosen based on their 
positive stability results in double and triple fortified salt, previously studied by our 
group. 
Potassium iodate and potassium iodide are most commonly used for salt 
iodization and were also used in this study. 
White starch and yellow dextrin were used as binders to granulate the 
micronutrients. 
The ability of three hydrophilic (Methocel, Ethocel and Shellac) and one 
hydrophobic (soy stearine) coating agents to protect the active ingredients from the high 
humidity environment was also studied. 
BHA, BHT and TBHQ are fat soluble antioxidants which were used to stabilize 
the vitamin A premix. 
6.2 Equipment 
Two stainless steel rotating pans were used for both wet agglomeration and 
spray coating. The pans were 26 cm and 13 cm in diameters and 6 cm deep. A 250 mL 
hand sprayer bottle from VWR was used as an atomizer to spray the binding and 
coating solutions. 
Blending of both, solid powders prior to granulation and salt with premixes, was 
done in a glass or plastic jar by shaking for 10 minutes on a shaking apparatus (Burrell 
wrist action shaker model #75, Burrell Corp., Pittsburg, PA, USA). Grinding was done 
using a Braun coffee grinder. 
UV-Vis spectroscopy was done with a UV-Vis Spectrophotometer, Beckman 
Coutler, model DU-7U. The fluorescent emission was measured with a Perkin Elmer 
Luminiscence Spectrophotometer, model LS 50B. 
6.3 Experimental Procedures 
6.3.1 Pan Agglomeration 
Wet agglomeration was used to granulate the premix. Steps involved in 
granulation were 
• blending 





Well blended material consisting of fillers and active ingredients was placed in a 
rotating pan. The pan was angled at approximately 45 degrees and rotated at about 50 
rpm. The speed depended on the size of the pan used and the amount of material 
granulated. A hand sprayer was used to spray the binding solution, which was usually 
water or water- ethanol solution. Once the material in the pan was free flowing and the 
size of the particles increased sufficiently, the material was dried in a Blue M oven from 
Blue M Electric Company, Blue Island, IL, model number OV-490A-3 at 60°C. After 
drying, the material was sieved using the Ro-Tap sieve shaker. Two Tyler standard US 
Mesh sieves with sizes 300 and 710 pm were used. Particles falling into this range 
were used in the coating process. 
6.3.2 Microencapsulation 
The microencapsulation was also done in the pan agglomerator. The granulated 
and screened particles were placed into the rotating pan and the angle and rotation 
speed were set to approximately the same values as for the agglomeration. The 
granules were coated with coating agents dissolved in hot solvents (either ethanol-water 
solution or dichloromethane) using the hand sprayer. The air inlet was set at 
approximately 3 5 psig. The concentration of the coating solution was dependent on 
the coating agent used. In case of soy stearine, 20% w/v solution was needed. For 
other coating agents, 30-40% solutions were sufficient. 
Dichioromethane evaporated practically immediately and no additional drying 
step was needed. When ethanol-water solution was used as solvent, an additional 
drying step was required (—15 mm at 60°C). The level of encapsulation was determined 
by weighing the particles before and after each run. 
6.4 Analytical Methods 
6.4.1 The Sampling Method 
The sampling technique relied on the concept of random sampling. A set of nine 
fractions was built from a bulk of sample so that each fraction contained all the 
characteristics, including particle size distribution, as the bulk from which they all came. 
Each sample was built from these fractions by a process of multiple additions so 
that a statistically representative image of the bulk existed in each of the newly created 
sample fractions. 
6.4.2 Vitamin A Analysis 
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A standard fluorometric method [47] was used for vitamin A analysis. This 
method is based on measurement of fluorescence of retinol and retinol esters in hexane 
after appropriate cleanup which separates the vitamin A from other lipids in the sample 
matrix. The hexane extract is excited by radiation at 330 nm and the fluorescent 
emission is measured at 480 nm. The fluorescence of retinol is a linear function of 
concentration from zero to 0.25 At higher concentrations self-absorption 
becomes significant. [48] 
The method consists of saponification (also called alkaline hydrolysis), extraction 
and measurement of fluorescence. 
During saponification, 70% potassium hydroxide solution and 1% ethanolic 
pyrogallol are used to free the vitamin A from fat and to convert the retinol esters into 
retinol (vitamin A alcohol). After saponification, most of the saponifiable material 
becomes soluble in polar solvents. Vitamin A can be then extracted with hexane. 
The fluorescence was measured with a Perkin-Elmer Luminescence 
Spectrometer, Model LS 50B, FE Shelton, Connecticut. The details can be found in 
Appendix 9.1.1. 
6.4.3 Iron Analysis 
Spectrophotometric determination of iron developed by Harvey, Smart and 
Edwards (1955) was used [49]. When 1, 10-phenantroline is added to a solution 
containing both ferrous and ferric irons, a reddish orange ferrous complex and a yellow 
ferric complex form immediately. The iron (II) complex has an absorbance maximum at 
512 nm. The two complexes have identical extinction coefficients at 396 nm. The 
absorbance was determined with a Beckman Coulter model DU-7U, UV Spectrometer. 
The details are presented in Appendix 9.1.2. 
6.4.4 Iodine Analysis 
6.4.4.1 Determination of Potassium Iodide 
The iodine content was determined using epithermal neutron activation analysis 
(ENAA), using the slowpoke reactor at the Royal Military College in Kingston, Ontario. 
I to 2 g of sample was weighed into a polyethylene vial. The sample vials were 
then shielded in cadmium and irradiated at I kW for 3 minutes using a neutron flux of 
5.0 x 1011 cm2sec* The samples were rested for 6 minutes and the gamma emissions 
were measured at 443 keV using a hyperpure germanium based gamma ray 
spectrometer. The concentration of iodine was calculated from the calibration curve 
obtained using series of standards covering a range of 0 to 1000 ppm. [50] 
6.4.4.2 Determination of Potassium lodate 
lodate was determined by iodometric titration using AOAC standard method 
33.149 [51]. This method is based on reduction of iodate to free iodine, which forms a 
deep blue color with starch. The free iodine is then titrated with standardized solution of 
sodium tiosulphate. The details are presented in Appendix 9.1.3. 
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6.4.5 Moisture Content Determination 
Moisture content was determined gravimetrically. Approximately 20g samples 
(w) were dried at 105°C for 24 hours. After cooling down the samples were weighed 
(Wf). The weight difference is assumed to be the moisture content. 
Moisture [%] = (w — Wf) * 100 % I 
w — initial weight, before drying [g] 
wf—final weight [g] 
6.4.6 Particle Size Distribution 
The analysis was performed using the Ro-Tap sieve shaker (figure 3.1). A stack 
of three Tyler standard US Mesh sieves with sizes 300 tim, 500 and 710 was 
used. Approximately 50g samples were shaken for 10 — 15 minutes. The separated 
parts were weighed and the fraction (% by weight) of the particles accumulated between 
two neighboring sieves was determined. 
Mean particle diameter retained by a screen is the sum of the aperture of the 
screen on which the material is retained, plus the aperture of the next largest screen, 
divided by 2. Mean particle diameter of a sample is the sum of the mass fractions 
retained on each screen multiplied by the mean diameter of particles retained by that 
screen. 
6.5 Packaging, Storage Conditions and Sample Handling 
Each sample formulation was prepared in six 150g replicates, packed in 
polyethylene "Ziploc" bags, 18 x 15 cm. The samples were stored under two 
conditions for three months (hence the replicates, table 3.3): 
• high temperature, high humidity (40°C, 100% RH) 
• high temperature, medium humidity (40°C, 60% RH) 
The 40°C and 60% RH setting is a good estimate of the average conditions in 
tropical environment. A relative humidity of 100% was chosen as the extreme condition 
that TFS is expected to encounter during storage, transportation and distribution. 
The high temperature and high humidity conditions were maintained using 
controlled temperature oven. The approximately 100% relative humidity was achieved 
by placing a tray of water into the oven thus obtaining approximately saturated air. 
The high temperature and medium humidity conditions were maintained in an 
environmental chamber type ZH-8-1-HIAC, manufactured by Cincinati Sub-Zero Co., 
Cincinnati, OH, USA. The stability of the micronutrients was determined monthly. 
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7. Results and Discussions 
Figure 4.1 shows a microscopic image of salt fortified with all three micronutrients 
(60 x magnification). The micronutrients were granulated with dextrin to match the size 
range of salt crystals and coated with soy stearine to protect them from a high 
temperature (4000) and high humidity (60% RH or '-100% RH) environment. The 
vitamin A and iodine premixes were slightly yellow in colour, the ferric NaEDTA was off- 
white. 
7.1 Premix Formulations 
From the nine commercial vitamin A sources, 36 premixes were prepared and 
tested both alone and after being mixed with the salt. The targeted vitamin A 
concentration in each of them was 25 000 IU/g of premix which would give the desired 
250 lU/g salt at I % addition level. 
Three main types of vitamin the A premix were produced: 
1. Premix containing only vitamin A as the active ingredient. 
2. Premix containing vitamin A and iodine (either as iodide or as iodate). 
3. Premix containing all three micronutrients in one particle. 
The premix containing source vitamin A and iron in one particle was studied 
previouslyby our group [56], and the retention of vitamin A was between 80% (ferric 
NaEDTA) and 20% (ferrous sulphate) after two months of storage in 40°C 60% RH. 
All vitamin A sources were granulated with either Casco Dextrin CAS: 9004-53-9 
(yellow) or Casco Starch CAS: 9005-25-8 (white) and encapsulated with Soy Stearine 
(30% or 40%), Shellac (40%) or Methyl Cellulose (MC) and Hexaethyl Cellulose (HEC). 
The antioxidants used to stabilize the vitamin A premix were either BHA and BHT (in 1:1 
ratio) or TBHQ. 
The composition of all the premixes used in this study is shown in Tables 7.1 to 
7.5. Table 7.1 shows the premix formulations which were coated with 40% soy 
stearine. These vitamin A premixes were mixed with potassium iodate or iodized salt 
and one of the four iron premixes to form the TFS. Vitamin A premixes coated with 
Shellac can be found in Table 7.2. Premixes containing all three micronutrients in one 
particle are listed in Table 7.3. The composition of the vitamin A premixes encapsulated 
with MC/HEC (level of encapsulation is 40%) are shown in Table 4.4. Lastly, Table 4.5 
lists the composition of various premix and TFS formulations: (a) TFS formed with 
vitamin A premix mixed with KI and iron premixes, (b) vitamin A granulated with a 
source of iodine, and (c) vitamin A coated with 30% of soy stearine. 









KR20-1 BASF Dry VAP 250 Food 
Lot:20071 9Y0 
Dextrin BHA/BHT 40%SS 
KR20-2 BASF Dry VAP 250 Food 
Lot:20071 9Y0 
Dextrin TBHQ 40%SS 
KR2I BASF Dry VAP 250 Food 
Lot:20071 9Y0 
Starch TBHQ 40%SS 
KR22 BASF Dry VAP 250 CK CWD TBHQ 1 40%SS 
KR23-1 BASF Dry VAP 250 CK CWD 
1 
Starch BHNBHT 40%SS 
KR23-2 BASE Dry VAP 250 OK CWD Starch TBHQ 40%SS 
KR24-1 BASE Dry VA Acetate 325 GEP Dextrin BHAIBHT 40%SS 
KR24-2 BASF Dry VA Acetate 325 GFP Dextrin TBHQ 40%SS 
KR25-1 BASE Dry VAP 250 Food 
Lot:4831 11 UO 
Dextrin BHAIBHT 40%SS 
KR25-2 BASE Dry VAP 250 Food 
Lot:4831 11 UO 
Dextrin TBHQ 40%SS 
KR26-1 BASE Dry VAP 250 CWD Dextrin BHAIBHT 40%SS 
KR26-2 BASE Dry VAP 250 CWD Dextrin TBHQ 40%SS 
KR27-1 BASF Dry VAP 500 
1 
Dextrin BHA/BHT 40%SS 
KR27-2 BASE Dry VAP 500 Dextrin TBHQ 40%SS 
KR28-1 BASE Dry VA Acetate 500 Dextrin BHAIBHT 40%SS 
KR28-2 BASE Dry VA Acetate 500 Dextrin TBHQ 40%SS 
KR29-1 1 Roche Dry VAP 500 BHAIBHT 40%SS 
KR29-2 Roche Dry VAP 500 Dextrin TBHQ 40%SS 
KR30-1 Roche Dry VAP 250 SIN Dextrin BHAIBHT 40%SS 
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Sample Vitamin A Binder Antioxida Encapsula 
KR30-2 Roche VAP 250 SIN Dextrin TBHQ 40%SS 
KR31-1 Watson VAP 250,000 lUIg Powder Dextrin BHAIBHT 40%SS 
KR31-2 Watson VAP 250,000 IU/g Powder Dextrin TBHQ 40%SS 
Table 7.2: Composition of the vitamin A premixes encapsulated with 
Shellac 
Sample Vitamin A Binder Antioxidant Encapsulant 
KRII Watson VAP 250,000 IU/g Dextrin TBHQ 40% Shellac 
Powder 
TBHQ 40% Shellac KR12 BASF VAP 250 Food Dextrin 
Table 7.3: Composition of the premixes containing all three micronutrients in one 
particle 
Sample Vitamin A Binder Antioxidant Encapsulant note 
KR13-1 Watson VAP 
250,000 lu!9 
Powder 
Dextrin TBHQ 40%SS with FeFum and 
Kb3 in one particle 
KR13-2 Watson VAP 
250,000 lU!g 
Powder 
Dextrin TBHQ 40%SS with Fe NaEDTA 
and Kl03 in one 
particle 
KR14-1 Watson VAP 
250,000 lU/g 
Powder 
Dextrin TBHQ 30%SS with FeFum and 
Kb3 in one particle 
KRI4-2 Watson VAP 
250,000 lu!9 
Powder 
Dextrin TBHQ 30%SS with Fe NaEDTA 
and K103 in one 
particle 
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Table 7.4: Composition of the vitamin A premixes encapsulated with MC/HEC 
(level of encapsulation was 40%) 
Sample Vitamin A Binder Antioxidant Encapsulant 
KRI5 Watson VAP 250,000 lUig 
Powder 
Dextrin TBHQ 30% MCI 10 
%HEC 
KR16 Watson VAP 250,000 IU/g 
Powder 
Dextrin TBHQ 20% MC! 20 
%HEC 
Table 7.5: Composition of the premixes and TFS samples containing various 
sources of iodine. Components of premixes_coated with 30% SS. 
Sample Vitamin A Binder Antioxidant Encapsulant Source of 
Iodine in TFS 




TBHQ 40%SS KI premix 




TBHQ 40%SS K103 and vit A 
in one particle 




TBHQ 40%SS KI and vit A in 
one particle 




TBHQ 30%SS Kl03 premix 
KR19-2 BASF Dry VAP 250 Food Dextri 
n 
TBHQ 30%SS K103 premix 
The coated vitamin A premixes were slightly yellow in colour. 
were mixed with an iron premix and an iodine premix or iodized salt. Total of 120 
samples were prepared for each test condition (40°C 60% RH and 40°C —100% RH). 
When iodine premix or the vitamin A premix containing source of iodine (either in the 
form of potassium iodide or potassium iodate) was used, the non-iodized salt was used 
for sample preparation. 
These premixes 
Four iron premixes were prepared using one of the following iron compounds: 
Electrolytic iron, reduced 
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• Ferrous Fumarate 
• Ferrous Sulphate, heptahydrate 
• Ferric Sodium EDTA 
Both iron and iodine premixes were granulated with dextrin and coated with 40% 
soy stearine. The colour of the iodine premixes was yellowish. Elemental iron gave 
grey premix, ferrous fumarate gave white premix with brown spots (showing defects in 
coating), ferrous sulphate was off white and the premix containing Fe NaEDTA was 
sandy in colour. Figure 4.2 shows the appearance of typical vitamin A, iron and iodine 
premixes. 
7.3 Stability of Vitamin A 
The results (Figures 4.3. and 4.4) show that overall vitamin A is highly unstable 
under the studied conditions. The average retention of vitamin A in TFS after three 
months at 40°C 60% RH and 40°C —'100% RH was 39 ± 1% and 31 ± 1%, respectively. 
Although there is a wide range within both RH studies, seven of the commercially 
available forms of vitamin A in 40°C 60% RH and five in 40°C —100% RH demonstrated 
above average stability. These included: 
• BASF Dry VAP 250 Food (premix KR2O in both RH and KR25 in 40°C 60% RH) 
• BASF Dry VAP 250 CK CWD (premix KR22 in 40°C and both RH) 
• BASF Dry VA Acetate 325 GFP (premix KR24 in 40°C 60% RH) 
• BASF Dry VAP 500 (premix KR27 in 40°C and both RH) 
• Roche Dry VAP 500 (premix KR29 in 40°C and both RH) 
• Roche Dry VAP 250 SIN (premix KR3O in 40°C 60% RH) 
• Watson VAP 250,000 lU/g Powder (premix KR 31 in 40°C —100% RH) 
The instability of some vitamin A samples in particular demonstrates the 
importance of choosing an appropriate source of commercial vitamin A. It is clear that 
the processes used for commercial stabilization of vitamin A have a major effect on the 
vitamin's stability in the triple fortified salt. 
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Figure 10: Stability of vitamin A premixes, granulated with dextrin, coated 
with 40% SS and stabilized with either BHA/BHT (marked with number 1) or TBHQ 
(marked with number 2), in the presence of iron and potassium iodate premix. 
The sample containing KR221 premix was prepared with iodized table salt. The 
TFS samples were stored for three months at 40°C 60% RH. 
In 40°C 60% RH vitamin A was most stable when ferric NaEDTA was used. In 
contrast, the lowest stability was observed under these conditions when ferrous 
fumarate was used. The same trends were not observed at 40°C —100% RH. At 40°C 
—100% RH the reverse was true: the best stability of vitamin A was achieved with 
ferrous fumarate and the worst with ferric NaEDTA. Because the difference between 
these results is less than 5%, the source of iron was not a major factor affecting the 
stability of vitamin A. Nonetheless, as shown in the previous research done by our 
group [56], iron is a major contributor to the instability of TFS. 
Figure 11: Stability of vitamin A premixes, granulated with dextrin, coated 
with 40% SS and stabilized with either BHA/BHT or TBHQ, in the presence of 
different iron compounds and potassium iodate premix. The TFS samples were 
stored for three months at 40°C 60% RH. 
Stability of vitamin A with different iron compounds 
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The decrease in vitamin A in TFS as a function of time was found to be 
consistent with a first order reaction rate. The first order reaction rate constants (k) were 
calculated to be (Figure 4.7) 0.15/month (5.8x108 s1) at 40°C 60% RH and 0.3/month 
(1.2 x107s1) at RH for sample containing KR 27-1 premix (BASF Dry VAP 500) 
and ferric NaEDTA (R2 (RSQ) 0.94 and 0.97, respectively). The results confirm that, as 
expected, the rate of degradation of vitamin A was slower in the lower humidity 
environment. 
Degradation rate of KR27-1 premix in the 
presence of Fe N aEDTA 
tim e (m o ) * 60% RH — 100% RH Linear (60% RH) Linear (100% RH) 
Figure 12: Degradation rate of vitamin A premix KR 27-1 (BASF Dry VAP 
500 granulated with dextrin, coated with 40% SS and stabilized with BHAIBHT) in 
TFS sample containing ferric NaEDTA. The TFS sample was stored for three 
months at 40°C 60% RH and RH. 
Five premixes showed stability higher than 48% after three months at 40°C, 60% 
RH. The highest stability of 55 ± 2% was achieved in the sample which contained 
elemental iron and vitamin A stabilized with BHA/BHT. 
BASF Dry VAP 500 is recommended by the manufacturer particularly for 
products with high moisture content, and for preparations that are to be stored in 
climates with high relative humidity. The stability of this vitamin A in the dry powder is 
supposed to be very good even in the presence of minerals. The product contains 
500,000 l.U./g of vitamin A. 
This vitamin A product was granulated with dextrin, coated with 40% soy stearine 
and stabilized with 27-1: BHNBHT (1:1 ratio) or 27-2: TBHQ. Reasonable stability was 
observed in both RH environments. 
The samples containing elemental iron showed high vitamin A retention, with 65 
± 2% retained (sample Fe elem-1) at 40°C 60% RH and as much as 44 ± 6% (sample 
Fe elem-2) at 40°C —100% RH. Fe NaEDTA-1 sample retained 61 ± 5% of vitamin A at 
40°C 60% RH and just under 40% at 40°C —100% RH. 
Overall, four out of the eight TFS samples containing KR22 premix (BASF Dry 
VAP 250 CK CWD) gave vitamin A retentions greater than 50% after two months of 
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storage at 40°C 60% RH. In addition, two samples retained more than 40% of this 
vitamin A at 40°C —100% RH after the same period of time. 
In the case of premix KR25 (BASF Dry VAP 250 Food), three 
showed retention greater than 50% at 40°C 60% RH, but none of them 
than 40% of vitamin A at 40°C —100% RH after three months of storage. 
TFS samples 
retained more 
TFS samples containing premix KR27 (BASF Dry VAP 500) showed very good 
stability under both RH conditions. At 40°C 60% RH, two samples retained more than 
60% of vitamin A and at 40°C —100% RH three samples showed retention higher than 
40% after three months of storage under these conditions. 
All three vitamins (BASF Dry VAP 250 CK CWD, BASF Dry VAP 250 Food and 
BASF Dry VAP 500) should be investigated further as they show promising stability in 
IFS samples. Altering the composition of their matrix and coating agents could 
promote their stability even more. 
Vitamin A Acetate vs. Palm itate 
The effect of different vitamin A esters on the vitamin's stability in TFS was 
evaluated by comparing the stability of vitamin A acetate and palmitate. In general, 
vitamin A palmitate showed better stability than the acetate form under all experimental 
conditions. This is most likely due to the differences in chemical structure between the 
acetate and palmitate forms. 
Figure 12: Stability of vitamin A acetate and palmitate premixes 
(granulated with dextrin, coated with 40% SS and stabilized with either BHA/BHT 
or TBHQ), in the presence of elemental iron and potassium iodate premix. The 
sample containing KR22i premix (1-Palm) was mixed with iodized salt. The TFS 
samples were stored for three months at 40°C 60% RH. 
Effect of Iron Source on Vitamin A Stability 
The influence of iron source on vitamin A stability was tested using the three 
most stable premixes, KR22 (BASF Dry VAP 250 CK CWD), KR25 (BASF Dry VAP 250 
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and vitamin A stabilized with TBHQ were studied. Ferric EDTA was marginally more 
stable than the other iron sources. 
Figure 13: Effect of iron source on the stability of vitamin A in premix KR 22 
(BASF Dry VAP 250 CK CWD, granulated with dextrin, coated with 40% SS and 
stabilized with TBHQ), in the presence of different iron compounds and 
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